XML 94 R73.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Other Intangibles - Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Apr. 01, 2019
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net $ 22,933 $ 14,101    
Intangible asset impairment charge related to marketed product     $ 705  
IPR&D impairment charges     172  
Contingent consideration liability, changes in estimated fair value 57 83    
Amortization expense for intangible assets 1,600 1,800 1,700  
Estimated aggregate amortization expense, 2022 1,700      
Estimated aggregate amortization expense, 2023 1,600      
Estimated aggregate amortization expense, 2024 1,600      
Estimated aggregate amortization expense, 2025 1,400      
Estimated aggregate amortization expense, 2026 1,400      
IPR&D        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 9,281 3,228    
Zerbaxa        
Intangible Assets Excluding Goodwill [Line Items]        
Intangible asset impairment charge related to marketed product   1,600    
Inventory write-down   120    
Sivextro        
Intangible Assets Excluding Goodwill [Line Items]        
Intangible asset impairment charge related to marketed product     612  
Animal Health        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 5,000      
Adempas | Licenses and other        
Intangible Assets Excluding Goodwill [Line Items]        
Intangible assets 806      
Verquvo | Licenses and other        
Intangible Assets Excluding Goodwill [Line Items]        
Intangible assets 68      
COVID-19        
Intangible Assets Excluding Goodwill [Line Items]        
IPR&D impairment charges   90    
Contingent consideration liability, changes in estimated fair value   (45)    
IOmet Pharma Ltd        
Intangible Assets Excluding Goodwill [Line Items]        
IPR&D impairment charges     155  
Contingent consideration liability, changes in estimated fair value     $ (11)  
sotatercept | IPR&D        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 6,400      
nemtabrutinib        
Intangible Assets Excluding Goodwill [Line Items]        
IPR&D impairment charges 275      
nemtabrutinib | IPR&D        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net $ 2,000      
nemtabrutinib | Measurement Input, Discount Rate | Valuation Technique, Discounted Cash Flow | Fair Value, Measurements, Recurring        
Intangible Assets Excluding Goodwill [Line Items]        
Discount rate 0.085      
gefapixant | IPR&D        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net $ 832      
Products and product rights        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 7,895 4,790    
Products and product rights | Reblozyl        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 3,800      
Products and product rights | Zerbaxa        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 478      
Products and product rights | Gardasil/Gardasil 9        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 191      
Products and product rights | Bridion        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 145      
Products and product rights | Dificid        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 145      
Products and product rights | Sivextro        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 138      
Products and product rights | Simponi        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 101      
Trade names        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 2,389 2,530    
License        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 3,368 $ 3,553    
License | Lynparza        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 1,100      
License | Lenvima        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net 1,000      
Antelliq | Measurement Input, Discount Rate        
Intangible Assets Excluding Goodwill [Line Items]        
Discount rate       0.115
Antelliq | Trade names        
Intangible Assets Excluding Goodwill [Line Items]        
Other intangibles, net $ 2,300